Cosmos Health Inc. (COSM)

AI Score

Unlock

0.35

-0.00 (-0.11%)

At close: Apr 07, 2025, 3:59 PM

0.36

3.01%

After-hours: Apr 07, 2025, 04:43 PM EDT

Dividends

No dividend history available for Cosmos Health Inc..

Pro Subscription

Upgrade now for unlimited access to all data and tools.

Dividend Definition

Dividends are payments made by a company to its shareholders, typically derived from its profits. They represent a portion of earnings distributed to investors as a reward for holding shares. Dividends do not account for retained earnings or reinvestments and are therefore different from a company's total profits.

Related Stocks

Company	Dividend Yield

Dividend Rankings

COSM News

1 month ago · Cosmos Health Expands Sky Premium Life Nutraceuticals Brand with 60 New SKUs as Global Growth Accelerates - accessnewswire.com
1 month ago · Cosmos Health Announces It will not Proceed with an Offering Under Its Form S-1 - accessnewswire.com
1 month ago · Cosmos Health Enters Final Development Phase of CCX0722 Weight Management Solution; Expected Product Launch in Q1 or Q2 2026, Gaining Access to Over $142 Billion Market - accessnewswire.com
1 month ago · Cosmos Health Advances Cancer Treatment Innovation with Two New AI-Driven Patent Filings for Gliomas and Hematologic Malignancies; $25 Billion+ Global Market - accessnewswire.com
1 month ago · Cosmos Health Strengthens Management Team with the Appointment of Veteran Executive Dimitris Moraitis as Vice President of Strategy & Operations - accessnewswire.com
1 month ago · Cosmos Health Secures 10-Year Long-Term Contract Manufacturing Order from Provident Pharmaceuticals for 4 Additional Products, Totaling 8 Million Packs, Significantly Expanding High-Margin Revenue Backlog and Cash Flow Visibility - accessnewswire.com
2 months ago · Cosmos Health Receives $578,460 Initial Purchase Order from Al Rabwa International for Sky Premium Life Food Supplements in Qatar - accessnewswire.com
2 months ago · Cosmos Health Files New AI-Driven Patent Application for Multiple Sclerosis Treatment, Targeting $25 Billion+ Global Market - accessnewswire.com
2 months ago · Cosmos Health Secures Bond Loan from European Bank on Very Competitive Terms, with Option to Upsize to Support Growth and Achieve Positive Operating Cash Flow - accessnewswire.com
2 months ago · Cosmos Health Submits Patent Application for Allergic Inflammation Therapy by Leveraging AI Drug Repurposing; Allergy Treatment Market Valued at $23.5 Billion - accessnewswire.com